ClinicalTrials.govcontrolled
Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.
ClinicalTrials.gov study NCT04642469. IPD Sharing: YES. Countries: 25. Publications: 0.
ShareScore
28/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 12
- Harmonization
- 8
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 4